Additionally, several studies reported the detection of SARS-CoV-2-specific CD8+ and CD4+ T cells in the majority of COVID-19 convalescent patients approximately 3–5 weeks PSO7,21–23. The gene discussed is CD8A; the disease is COVID-19.